| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_48fd3875bf86536031ad4ffbfbf07245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e247d0d3d5add3fd103484530f490a72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ea1fff38e27d2aa34504ab65f60e7631
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_db952cdd3f224c93d3f0607126e131f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b89e6191fc09ab378b52ebe5f59d91f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3afaf552fee64da9df64b95d4fc51159 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-553 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-14 |
| filingDate |
2009-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d29c245d313f00fc02982b3d7feb7681
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_056751d70af204b7bafcf3f36f84fab8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ed59939c4746dc676d681ee9851c374
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e8e082e1c1a1e02b5c70bafba5721e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb694c7aec4d506e08ea6d6d71a6aefa |
| publicationDate |
2010-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010027217-A2 |
| titleOfInvention |
Composition for preventing or treating alopecia caused by a chemotherapeutic agent |
| abstract |
The present invention relates to a topically applicable composition for preventing or treating alopecia caused by a chemotherapeutic agent, including a nanoliposome consisting of a liposome layer containing a lecithin, wherein the nanoliposome includes an epidermal growth factor. In addition, the present invention relates to a pharmaceutical combination which contains the above-described composition and chemotherapeutic agent such that the composition and the chemotherapeutic agent can be individually administered. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101874780-A |
| priorityDate |
2008-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |